NYSE · Medical - Instruments & Supplies

Bausch + Lomb Corporation (BLCO) Stock

$17.47 +0.23% NYSE: BLCO Healthcare

Valuation

MetricValue
Price$17.47
Market Cap$6.24B
P/E Ratio-35.85
P/B Ratio0.96
P/S Ratio1.15
EPS (TTM)$0.00
52-Week High$18.92
52-Week Low$13.77
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-2.67%
ROA-1.23%
ROCE3.17%
Gross Margin55.86%
Operating Margin5.91%
Net Margin-3.21%
Debt/Equity0.80
Current Ratio1.55

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.8B$3.8B$4.1B$4.8B$5.1B
Operating Profit$329.0M$207.0M$130.0M$162.0M$188.0M
Net Profit$182.0M$6.0M$-260.0M$-317.0M$-360.0M
EPS$0.52$0.04$-0.74$-0.90$-1.02
Op Margin8.7%5.5%3.1%3.4%3.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.8B$11.1B$13.4B$13.5B$14.0B
Total Liabilities$1.4B$4.0B$6.5B$6.9B$7.5B
Cash$174.0M$380.0M$334.0M$305.0M$383.0M
Borrowings$140.0M$2.6B$4.7B$4.9B$5.4B

Latest News

Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States Business Wire · Jul 16, 2026 Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others GlobeNewswire · Jul 13, 2026 Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today StockStory · Jul 10, 2026 Sector Update: Healthcare Stocks Decline Late Afternoon MT Newswires · Jul 10, 2026 Sector Update: Healthcare Stocks Decline Friday Afternoon MT Newswires · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$873.0M$345.0M$-17.0M$232.0M$283.0M
Investing Cash Flow$-407.0M$-390.0M$-2.3B$-703.0M$-804.0M
Financing Cash Flow$-740.0M$-2.4B$-37.0M$-23.0M$-24.0M
Net Cash Flow$-61.0M$203.0M$-46.0M$-18.0M$81.0M
Free Cash Flow$680.0M$170.0M$-198.0M$-59.0M$-66.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.44
EV / EBITDA14.65
FCF Yield2.29%
Quick Ratio1.02
Interest Coverage0.96
Return 1Y16.27%
Return 3Y3.19%
Return 5Y—

About Bausch + Lomb Corporation

Bausch + Lomb Corporation (BLCO) stock trades at $17.47 with a market capitalization of $6.24B. The stock is valued at a negative price-to-earnings (P/E) ratio of -35.85, reflecting a net loss over the last twelve months, price-to-book of 0.96, price-to-sales of 1.15. Over the past 52 weeks the stock has ranged between $13.77 and $18.92, and currently trades 7.7% below its 52-week high.

On profitability, Bausch + Lomb Corporation generates a return on equity (ROE) of -2.67% (negative, reflecting a net loss), return on capital employed of 3.17%, an operating margin of 5.91%, a net profit margin of -3.21%.

Bausch + Lomb Corporation by the numbers, 2018–2025

Between 2018 and 2025 Bausch + Lomb Corporation reported revenue of $3.7B rising to $5.1B, a change of +39.2% across 8 years. Compounded, revenue has grown 8.4% a year over five years, 10.6% over three, 6.5% over the last twelve months. Net profit fell to $-360.0M.

Operating margin went from 11.3% in 2018 to 3.7% in 2025, a fall of 7.7 percentage points. The most recent net margin is -3.21%. On a trailing twelve-month basis to Jun '26, revenue is $5.3B and net profit $-171.0M.

Borrowings stand at $5.4B, cash from operations was $283.0M in the latest year, positive in 7 of the last 8.

Return on equity has averaged -2.5% over five years, and was -5.6% in the most recent year.

The share price itself has compounded at —% a year over five years, -8.5% over three, 21.9% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Bausch + Lomb Corporation (BLCO) — frequently asked questions

What is Bausch + Lomb Corporation (BLCO) stock price today?

Bausch + Lomb Corporation (BLCO) is currently trading at $17.47, up 0.23% today.

What is BLCO P/E ratio?

Bausch + Lomb Corporation's P/E ratio is -35.85. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is BLCO return on equity (ROE)?

Bausch + Lomb Corporation's return on equity (ROE) is -2.67%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Bausch + Lomb Corporation's market cap?

Bausch + Lomb Corporation has a market capitalization of $6.24B.

Does BLCO pay a dividend?

Bausch + Lomb Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does BLCO carry?

Bausch + Lomb Corporation has a debt-to-equity ratio of 0.80. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is BLCO's profit margin?

Bausch + Lomb Corporation reports a net profit margin of -3.21% — the share of revenue left after every cost, including tax and interest.

What sector is BLCO in?

Bausch + Lomb Corporation is classified under Healthcare, in the Medical - Instruments & Supplies industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is BLCO listed on?

Bausch + Lomb Corporation trades on NYSE under the ticker BLCO.

What is BLCO's 52-week range?

Over the last year Bausch + Lomb Corporation has traded between $13.77 and $18.92.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens BLCO currently matches

On the figures above, Bausch + Lomb Corporation passes the filters for 7 of our ready-made screens, among them Low PB Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low PB StocksStocks Under $100Stocks Under $50High Gross Margin StocksMid Cap StocksNYSE Listed StocksDebt to Equity Below 1 Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.